Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
45 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Generally healthy Asian women 45 years of age or older who are at least 1 year postmenopausal
Subjects must qualify for one of the following categories (a or b):
Greater than 1 year but less than 5 years postmenopausal with at least one of the ospeoporosis risk factors
Equal or greater than 5 years postmenopausal with BMD T-score at lumbar spine or femoral neck between -1 and -2.5 (values of -1 and -2.5 are acceptable) with at least one osteoporosis risk factor
One (1) or more osteoporotic vertebral fractures (T4 - L4)
BMD T-score at the lumbar spine or femoral neck less than -2.5
Past history or active nontraumatic venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis